Co-Founder & Ceo
CurrentEngage Bio is developing Tethosomes, the next generation of non-viral DNA medicines. Tethosomes are highly potent, non-immunogenic, redosable, and titratable. At Engage, we're focused on building genetic medicines that scale. www.engagebio.com